Request Trial
L-R: Rob Rodrigues, RNA Law; Nicole Mastrangelo, The Broad Institute; Isaac Zaghi, Endologix; and Carsten Richter, Eurolmmun
3 December 2024NewsEuropeSarah Speight

LSPN Europe: Navigating the EPO and lessons from the UPC frontline

One-day event in London brings in-house counsel and private practitioners together | First sessions to kick off the day covered European Patent Office procedures, and in-house views on how the UPC is faring.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
INTA: ‘Davos of IP’ will take London meeting to a ‘different level’
5 February 2026   Excitement is mounting for the world’s largest IP gathering, which will see the industry’s elites travelling to the UK in the spring, reveals the association’s CEO.
Europe
Drowning in EU regulations? Five tips for surviving the deluge of new rules
3 February 2026   As legislative activity in life sciences increases, in-house teams are struggling to keep up. Experts share their sources and strategies for monitoring developments, coordinating internally, and knowing when to engage.
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026   A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

The curtain has closed for three major drug disputes
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Novartis takes aim at Tafinlar generic in latest suit
Semaglutide patent battle heats up with new blow for Novo in India
Wilson Sonsini senior counsel moves to a rival firm
AstraZeneca partners with Chinese firm ahead of next obesity race
INTA: ‘Davos of IP’ will take London meeting to a ‘different level’
Nine-partner litigation team leaves Winston & Strawn